Shanghai mRNA COVID-19 vaccine begins phase 1 clinical trials

A new Chinese mRNA COVID-19 vaccine, developed by scientists and medical personnel in Shanghai, started Phase I clinical trials among adults on Thursday.
( read original story …)

---